Tier 2 — strong

Effects of Betaine Supplementation on Markers of Metabolic Flexibility, Body Composition, and Anaerobic Performance in Active College-Age Females

Hunter S Waldman, Andrea R Bryant, Matthew J McAllister
Journal of dietary supplements 2023 20(1):89-105

Bibliography

PubMed
PMID 34477469
Funding
Funding was not specified in the indexed record or accessible funding metadata.
Competing interests
A competing-interest declaration was not available in the indexed record or accessible disclosure metadata.

Study snapshot

DesignRandomized controlled trial
ModelHuman participants
Sample23 active college-age women
InterventionBetaine 2.4 g/day versus placebo
Duration2 weeks
EndpointsSubstrate oxidation; Body composition; Sprint performance

What the study showed, in plain terms

Published in 2023, this source examined exercise performance and body composition. Design: Randomized controlled trial. Sample/model: 23 active college-age women. The exposure or intervention was Betaine 2.4 g/day versus placebo. Follow-up or treatment period: 2 weeks.

The study reported selected lean-mass, final-sprint and perceived-exertion signals, but no clear change in substrate oxidation.

Several reported benefits were within-group changes; brief treatment and a small sample limit conclusions about a reproducible treatment effect.

Continue with TMG Data Center

Continue with TMG for Weight Loss: Body-Fat Findings and Their Limits

Key findings

  • The study reported selected lean-mass, final-sprint and perceived-exertion signals, but no clear change in substrate oxidation.
  • The recorded outcome domains were Substrate oxidation; Body composition; Sprint performance.
  • The result applies to the tested exposure: Betaine 2.4 g/day versus placebo; 2 weeks.

What this study can and cannot tell us

  • Several reported benefits were within-group changes; brief treatment and a small sample limit conclusions about a reproducible treatment effect.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Indexed abstract and bibliographic data. Missing method details, funding information or participant denominators are not inferred.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified